271
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Nanoemulsifying drug delivery system to improve the bioavailability of piroxicam

, , &
Pages 445-456 | Received 05 Apr 2016, Accepted 11 Aug 2016, Published online: 25 Oct 2016

References

  • Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413–420.
  • Brayfield A. Martindale (the complete drug reference). 38th ed. London: The Pharmaceutical Press; 2014:125–127.
  • Park ES, Cui Y, Yun BJ, et al. Transdermal delivery of piroxicam using microemulsions. Arch Pharm Res 2005;28:243–248.
  • Nnamani PO, Attama AA, Kenechukwu FC, et al. Pharmacodynamics of piroxicam from novel solid lipid microparticles formulated with homolipids from Bos indicus. Curr Drug Deliv 2013;10:645–655.
  • Barzegar-Jalali M, Ghanbarzadeh S, Adibkia K, et al. Development and characterization of solid dispersion of piroxicam for improvement of dissolution rate using hydrophilic carriers. Bioimpacts 2014;4:141–148.
  • Pereira SV, Colombo FB, de Freitas LA. Ultrasound influence on the solubility of solid dispersions prepared for a poorly soluble drug. Ultrason Sonochem 2016;29:461–469.
  • Otarola J, Lista AG, Band BF, Garrido M. Capillary electrophoresis to determine entrapment efficiency of a nanostructured lipid carrier loaded with piroxicam. J Pharm Anal 2015;5:70–73.
  • Penkina A, Semjonov K, Hakola M, et al. Towards improved solubility of poorly water-soluble drugs: cryogenic co-grinding of piroxicam with carrier polymers. Drug Dev Ind Pharm 2016;42:378–388.
  • Franceschinis E, Bortoletto C, Perissutti B, et al. Self-emulsifying pellets in a lab-scale high shear mixer: formulation and production design. Powder Technology 2011;207:113–118.
  • Jannin V, Chevrier S, Michenaud M, et al. Development of self emulsifying lipid formulations of BCS class II drugs with low to medium lipophilicity. Int J Pharm 2015;495:385–392.
  • Marasini N, Yan YD, Poudel BK, et al. Development and optimization of self-nanoemulsifying drug delivery system with enhanced bioavailability by Box-Behnken design and desirability function. J Pharm Sci 2012;101:4584–4596.
  • Balakumar K, Raghavan CV, Selvan NT, et al. Self nanoemulsifying drug delivery system (SNEDDS) of rosuvastatin calcium: design, formulation, bioavailability and pharmacokinetic evaluation. Colloids Surf B Biointerfaces 2013;112:337–343.
  • Date AA, Desai N, Dixit R, Nagarsenker M. Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances. Nanomedicine 2010;5:1595–1616.
  • Heshmati N, Cheng X, Eisenbrand G, Fricker G. Enhancement of oral bioavailability of E804 by self-nanoemulsifying drug delivery system (SNEDDS) in rats. J Pharm Sci 2013;102:3792–3799.
  • Setthacheewakul S, Mahattanadul S, Phadoongsombut N, et al. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats. Eur J Pharm Biopharm 2010;76:475–485.
  • Beg S, Swain S, Singh HP, et al. Development, optimization, and characterization of solid self-nanoemulsifying drug delivery systems of valsartan using porous carriers. AAPS PharmSciTech 2012;13:1416–1427.
  • Singh B, Singh R, Bandyopadhyay S, et al. Optimized nanoemulsifying systems with enhanced bioavailability of carvedilol. Colloids Surf B Biointerfaces 2013;101:465–474.
  • Brouwers J, Brewster ME, Augustijns P. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J Pharm Sci 2009;98:2549–2572.
  • Thomas N, Holm R, Müllertz A, Rades T. In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS). J Control Release 2012;160:25–32.
  • Dash RN, Mohammed H, Humaira T, Reddy AV. Solid supersaturatable self-nanoemulsifying drug delivery systems for improved dissolution, absorption and pharmacodynamic effects of glipizide. J Drug Deliv Sci Technol 2015;28:28–36.
  • Pund S, Borade G, Rasve G. Improvement of anti-inflammatory and anti-angiogenic activity of berberine by novel rapid dissolving nanoemulsifying technique. Phytomedicine 2014;21:307–314.
  • Shafiq S, Shakeel F, Talegaonkar S, et al. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm 2007;66:227–243.
  • Atef E, Belmonte AA. Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS). Eur J Pharm Sci 2008;35:257–263.
  • Rai S, Yasir M. Cinnarizine loaded lipid based system: preparation, optimization and in-vitro evaluation. IOSR-Phr 2012;2:47–56.
  • Kallakunta VR, Bandari S, Jukanti R, Veerareddy PR. Oral self emulsifying powder of lercanidipine hydrochloride: formulation and evaluation. Powder Technol 2012;221:375–382.
  • Kang JH, Oh DH, Oh YK, et al. Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self-nanoemulsifying drug delivery system (solid SNEDDS). Eur J Pharm Biopharm 2012;80:289–297.
  • Inugala S, Eedara BB, Sunkavalli S, et al. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: in vitro and in vivo evaluation. Eur J Pharm Sci 2015;74:1–10.
  • Krishna V, Srinath KR, Chowdary CP, et al. Formulation development and evaluation of divalproex sodium extended release tablets. Int J Res Pharm and Biomed Sci 2011; 2:809–832.
  • USP. The United States Pharmacopeia. 34th Revision. Rockville, MD: The United States Pharmacopeial Convention; 2011:276–770.
  • Savaşer A, Karataş A, Özkan Y, et al. Validated LC determination of the piroxicam β-cyclodextrin inclusion complex in tablets and in human plasma. Chromatographia 2004;59:555–560.
  • Humberstone AJ, Charman WN. Lipid based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev 1997;25:103–128.
  • Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm 2000; 50:179–188.
  • Seo YG, Kim DH, Ramasamy T, et al. Development of docetaxel-loaded solid self-nanoemulsifying drug delivery system (SNEDDS) for enhanced chemotherapeutic effect. Int J Pharm 2013;452:412–420.
  • Shah NH, Carvajal MT, Patel CI, et al. Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm 1994;106:15–23.
  • Charman SA, Charman WN, Rogge MC, et al. Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res 1992;9:87–93.
  • Grove M, Pedersen GP, Nielsen JL, Mullertz A. Bioavailability of seocalcitol I: relating solubility in biorelevant media with oral bioavailability in rats - effect of medium and long chain triglycerides. J Pharm Sci 2005; 94:1830–1838.
  • Elgart A, Cherniakov I, Aldouby Y, et al. Improved oral bioavailability of BCS class 2 compounds by self nano-emulsifying drug delivery systems (SNEDDS): the underlying mechanisms for amiodarone and talinolol. Pharm Res 2013;30:3029–3044.
  • Wei Y, Ye X, Shang X, et al. Enhanced oral bioavailability of silybin by a supersaturatable self-emulsifying drug delivery system (S-SEDDS). Colloids Surf A Physicochem Eng Asp 2012;396:22–28.
  • Villalobos-Hernández JR, Müller-Goymann CC. Novel nanoparticulate carrier system based on carnauba wax and decyl oleate for the dispersion of inorganic sunscreens in aqueous media. Eur J Pharm Biopharm 2005;60:113–122.
  • Zhao Y, Wang C, Chow AH, et al. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: formulation and bioavailability studies. Int J Pharm 2010;383:170–177.
  • Jabbar ASA, Hussein AA. Formulation and evaluation of piroxicam liqusolid compacts. Int J Pharm Pharm Sci 2013;5:132–141.
  • Yüksel N, Karataş A, Ozkan Y, et al. Enhanced bioavailability of piroxicam using Gelucire 44/14 and labrasol: in vitro and in vivo evaluation. Eur J Pharm Biopharm 2003;56:453–459.
  • Balakrishnan P, Lee BJ, Oh DH, et al. Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems. Int J Pharm 2009;374:66–72.
  • Gwak HS, Choi JS, Choi HK. Enhanced bioavailability of piroxicam via salt formation with ethanolamines. Int J Pharm 2005;297:156–161.
  • Gumaste SG, Pawlak SA, Dalrymple DM, et al. Development of solid SEDDS, IV: effect of adsorbed lipid and surfactant on tableting properties and surface structures of different silicates. Pharm Res 2013;30:3170–3185.
  • Khan LG, Razvi N, Anjum F, et al. Effects of various excipients on tizanidine hydrochloride tablets prepared by direct compression. Pak J Pharm Sci 2014;27:1249–1254.
  • Abbaspour M, Jalayer N, Sharif Makhmalzadeh B. Development and evaluation of a solid self-nanoemulsifying drug delivery system for loratadin by extrusion-spheronization. Adv Pharm Bull 2014;4:113–119.
  • Balakrishnan P, Lee BJ, Oh DH, et al. Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS). Eur J Pharm Biopharm 2009;72:539–545.
  • DiNunzio JC, Hughey JR, Brough C, et al. Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol dispersing. Drug Dev Ind Pharm 2010;36:1064–1078.
  • Gao P, Morozowich W, Design and development of supersaturatable self-emulsifying drug delivery systems for enhancing the gastrointestinal absorption of poorly soluble drugs. In: Hauss DJ, ed. Oral lipid-based formulations enhancing the bioavailability of poorly water-soluble drugs. New Jersey (USA): CRC Press; 2007:303–324.
  • Mirza S, Miroshnyk I, Habib MJ, et al. Enhanced dissolution and oral bioavailability of piroxicam formulations: modulating effect of phospholipids. Pharmaceutics 2010;2:339–350.
  • Porter CJH, Pouton CW, Cuine JF, Charman WN. Enhancing intestinal drug solubilisation using lipid-based delivery systems . Adv Drug Deliv Rev 2008;60:673–691.
  • Caliph SM, Charman WN, Porter CJ. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J Pharm Sci 2000;89:1073–1084.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.